EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Computer-Aided Drug Design Across Breast Cancer Subtypes: Methods, Applications and Translational Outlook

Wei Tian iD, Ying Hu, Xinyu Gao, Jinghui Yang, Wei Jiang

International Journal of Molecular Sciences · 05.11.2025 · 26 (21) · 10744

DOI: 10.3390/ijms262110744 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 05.11.2025. Verfasst von Wei Tian und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Science and Technology, Wuhan Polytechnic University, Wuhan 430023, China. Hauptthemen laut MEDLINE: Breast Neoplasms, Drug Design, Computer-Aided Design, Antineoplastic Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 144 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: EDUCATIONAL COMMISSION OF HUBEI PROVINCE OF CHINA, RESEARCH PROJECT OF WUHAN POLYTECHNIC UNIVERSITY, SCIENCE AND TECHNOLOGY TALENT SERVING ENTERPRISES PROJECT OF HUBEI PROVINCIAL DEPARTMENT OF SCIENCE AND TECHNOLOGY.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer is a heterogeneous malignancy with distinct molecular subtypes that complicate the development of effective therapies. Traditional drug discovery methods are often constrained by high cost and long development timelines, underscoring the need for more efficient, subtype-aware approaches. Computer-aided drug design (CADD) has emerged as a valuable strategy to accelerate therapeutic discovery and improve lead optimization. This review synthesizes advances from a subtype-centric perspective and outlines the application of CADD techniques, including molecular docking, virtual screening (VS), pharmacophore modeling, and molecular dynamics (MD) simulations, to identify potential targets and inhibitors in receptor-positive (Luminal), HER2-positive (HER2+), and triple-negative breast cancer (TNBC). In addition to traditional pipelines, we highlight artificial intelligence (AI)-enabled methods and a hybrid workflow in which learning-based models rapidly triage chemical space while physics-based simulations provide mechanistic validation. These approaches have facilitated the discovery of subtype-specific compounds and enabled the refinement of candidate drugs to enhance efficacy and reduce toxicity. Despite these advances, critical challenges remain, particularly tumor heterogeneity, drug resistance, and the need to rigorously validate computational predictions through experimental studies. Future progress is expected to be driven by the integration of AI, machine learning (ML), multi-omics data, and digital pathology, which may enable the design of more precise, subtype-informed, and personalized therapeutic strategies for breast cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsDrug DesignComputer-Aided DesignAntineoplastic AgentsHumansFemaleMolecular Dynamics SimulationMolecular Docking SimulationErb-b2 Receptor Tyrosine Kinases

Stichwörter der Autor:innen

Computer-aided drug designHER2-positiveartificial intelligenceluminalmachine learningtriple-negative breast cancer

Substanzen

Antineoplastic AgentsErb-b2 Receptor Tyrosine Kinases

Autor:innen und Institutionen

  • School of Life Science and Technology, Wuhan Polytechnic University, Wuhan 430023, China.

ORCID-Profile: Wei Tian

Förderung

  • EDUCATIONAL COMMISSION OF HUBEI PROVINCE OF CHINA
  • RESEARCH PROJECT OF WUHAN POLYTECHNIC UNIVERSITY
  • SCIENCE AND TECHNOLOGY TALENT SERVING ENTERPRISES PROJECT OF HUBEI PROVINCIAL DEPARTMENT OF SCIENCE AND TECHNOLOGY
  • Hubei Provincial Department of Education

Zitieren

APA

Tian, W., Hu, Y., Gao, X., Yang, J., & Jiang, W. (2025). Computer-Aided Drug Design Across Breast Cancer Subtypes: Methods, Applications and Translational Outlook. International Journal of Molecular Sciences, 26(21), 10744. https://doi.org/10.3390/ijms262110744

Vancouver

Tian W, Hu Y, Gao X, Yang J, Jiang W. Computer-Aided Drug Design Across Breast Cancer Subtypes: Methods, Applications and Translational Outlook. International Journal of Molecular Sciences. 2025;26(21):10744. doi:10.3390/ijms262110744

BibTeX
@article{Tian2025,
  author = {Tian, Wei and Hu, Ying and Gao, Xinyu and Yang, Jinghui and Jiang, Wei},
  title = {Computer-Aided Drug Design Across Breast Cancer Subtypes: Methods, Applications and Translational Outlook},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {21},
  pages = {10744},
  doi = {10.3390/ijms262110744}
}
Kostenlos starten →